Molecular urothelial tumor cell subtypes remain stable during metastatic evolution

Urothelial cancer (UC) care is moving toward precision oncology. For tumor biology-driven treatment of metastatic UC (mUC), molecular subtypes play a crucial role. However, it is not known whether subtypes change during metastatic evolution. To address this, we analyzed a UC progression cohort (N =...

Full description

Saved in:
Bibliographic Details
Main Authors: Cox, Alexander (Author) , Klümper, Niklas (Author) , Stein, Johannes (Author) , Sikic, Danijel (Author) , Breyer, Johannes (Author) , Bolenz, Christian (Author) , Roghmann, Florian Bernhard Gerhard (Author) , Erben, Philipp (Author) , Wirtz, Ralph M. (Author) , Wullich, Bernd (Author) , Ritter, Manuel (Author) , Hölzel, Michael (Author) , Schwamborn, Kristina (Author) , Horn, Thomas (Author) , Gschwend, Jürgen E. (Author) , Hartmann, Arndt (Author) , Weichert, Wilko (Author) , Erlmeier, Franziska (Author) , Eckstein, Markus (Author)
Format: Article (Journal)
Language:English
Published: April 2024
In: European urology
Year: 2024, Volume: 85, Issue: 4, Pages: 328-332
ISSN:1873-7560
DOI:10.1016/j.eururo.2023.03.020
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.eururo.2023.03.020
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0302283823026982
Get full text
Author Notes:Alexander Cox, Niklas Klümper, Johannes Stein, Danijel Sikic, Johannes Breyer, Christian Bolenz, Florian Roghmann, Philipp Erben, Ralph M. Wirtz, Bernd Wullich, Manuel Ritter, Michael Hölzel, Kristina Schwamborn, Thomas Horn, Jürgen Gschwend, Arndt Hartmann, Wilko Weichert, Franziska Erlmeier, Markus Eckstein

MARC

LEADER 00000caa a2200000 c 4500
001 1902568621
003 DE-627
005 20241205172015.0
007 cr uuu---uuuuu
008 240916s2024 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.eururo.2023.03.020  |2 doi 
035 |a (DE-627)1902568621 
035 |a (DE-599)KXP1902568621 
035 |a (OCoLC)1475311651 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Cox, Alexander  |e VerfasserIn  |0 (DE-588)1342113551  |0 (DE-627)1902569555  |4 aut 
245 1 0 |a Molecular urothelial tumor cell subtypes remain stable during metastatic evolution  |c Alexander Cox, Niklas Klümper, Johannes Stein, Danijel Sikic, Johannes Breyer, Christian Bolenz, Florian Roghmann, Philipp Erben, Ralph M. Wirtz, Bernd Wullich, Manuel Ritter, Michael Hölzel, Kristina Schwamborn, Thomas Horn, Jürgen Gschwend, Arndt Hartmann, Wilko Weichert, Franziska Erlmeier, Markus Eckstein 
264 1 |c April 2024 
300 |b Illustrationen 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 6. April 2023, Artikelversion: 12. März 2024 
500 |a Gesehen am 16.09.2024 
520 |a Urothelial cancer (UC) care is moving toward precision oncology. For tumor biology-driven treatment of metastatic UC (mUC), molecular subtypes play a crucial role. However, it is not known whether subtypes change during metastatic evolution. To address this, we analyzed a UC progression cohort (N = 154 patients) with 138 matched primary tumors (PRIM) and synchronous or metachronous distant metastasis (MET) by immunohistochemistry, and mRNA sequencing in a subgroup of 20 matched pairs. Protein-based tumor cell subtypes and histomorphology remained stable during metastatic progression (concordance: 94%, 95% confidence interval [CI] 88-97%). In comparison, transcriptome-based molecular consensus subtypes exhibited higher heterogeneity between PRIM and MET (concordance: 45%, 95% CI 23-69%), with switches particularly occurring between luminal and stroma-rich tumors. Of note, all tumors classified as stroma rich showed luminal tumor cell differentiation. By an in-depth analysis, we found a negative correlation of luminal gene and protein expression with increasing desmoplastic stroma content, suggesting that luminal tumor cell differentiation of “stroma-rich tumors” is superimposed by gene expression signals stemming from the stromal compartment. Immunohistochemistry allows tumor cell subtyping into luminal, basal, or neuroendocrine classes that remain stable during metastatic progression. These findings expand our biological understanding of UC MET and have implications for future subtype-stratified clinical trials in patients with mUC. - Patient summary - Urothelial carcinomas (UCs) occur in different appearances, the so-called molecular subtypes. These molecular subtypes will gain importance for the therapy of metastatic UCs in the future. We could demonstrate that the subtype remains stable during metastasis, which is highly relevant for future studies. 
650 4 |a Metastatic evolution 
650 4 |a Metastatic urothelial carcinoma 
650 4 |a Molecular subtypes 
650 4 |a Subtypes 
650 4 |a Urothelial cancer 
700 1 |a Klümper, Niklas  |e VerfasserIn  |0 (DE-588)1293974110  |0 (DE-627)185095772X  |4 aut 
700 1 |a Stein, Johannes  |e VerfasserIn  |4 aut 
700 1 |a Sikic, Danijel  |d 1982-  |e VerfasserIn  |0 (DE-588)141368551  |0 (DE-627)627282350  |0 (DE-576)323536646  |4 aut 
700 1 |a Breyer, Johannes  |e VerfasserIn  |4 aut 
700 1 |a Bolenz, Christian  |d 1976-  |e VerfasserIn  |0 (DE-588)133152707  |0 (DE-627)537509852  |0 (DE-576)29965754X  |4 aut 
700 1 |a Roghmann, Florian Bernhard Gerhard  |d 1980-  |e VerfasserIn  |0 (DE-588)140688145  |0 (DE-627)620888156  |0 (DE-576)319420485  |4 aut 
700 1 |a Erben, Philipp  |d 1973-  |e VerfasserIn  |0 (DE-588)128501014  |0 (DE-627)373920997  |0 (DE-576)297181661  |4 aut 
700 1 |a Wirtz, Ralph M.  |e VerfasserIn  |4 aut 
700 1 |a Wullich, Bernd  |d 1960-  |e VerfasserIn  |0 (DE-588)110835794  |0 (DE-627)691096716  |0 (DE-576)302885749  |4 aut 
700 1 |a Ritter, Manuel  |e VerfasserIn  |4 aut 
700 1 |a Hölzel, Michael  |e VerfasserIn  |4 aut 
700 1 |a Schwamborn, Kristina  |d 1976-  |e VerfasserIn  |0 (DE-588)13043745X  |0 (DE-627)501474439  |0 (DE-576)29819547X  |4 aut 
700 1 |a Horn, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Gschwend, Jürgen E.  |d 1962-  |e VerfasserIn  |0 (DE-588)111741300  |0 (DE-627)523317697  |0 (DE-576)178294446  |4 aut 
700 1 |a Hartmann, Arndt  |e VerfasserIn  |4 aut 
700 1 |a Weichert, Wilko  |d 1970-2023  |e VerfasserIn  |0 (DE-588)123509106  |0 (DE-627)56134650X  |0 (DE-576)293740461  |4 aut 
700 1 |a Erlmeier, Franziska  |d 1985-  |e VerfasserIn  |0 (DE-588)107067804X  |0 (DE-627)824446550  |0 (DE-576)432206434  |4 aut 
700 1 |a Eckstein, Markus  |d 1990-  |e VerfasserIn  |0 (DE-588)1113210656  |0 (DE-627)867126388  |0 (DE-576)476917069  |4 aut 
773 0 8 |i Enthalten in  |t European urology  |d Amsterdam [u.a.] : Elsevier Science, 1976  |g 85(2024), 4 vom: Apr., Seite 328-332  |h Online-Ressource  |w (DE-627)300191596  |w (DE-600)1482253-2  |w (DE-576)099718103  |x 1873-7560  |7 nnas  |a Molecular urothelial tumor cell subtypes remain stable during metastatic evolution 
773 1 8 |g volume:85  |g year:2024  |g number:4  |g month:04  |g pages:328-332  |g extent:5  |a Molecular urothelial tumor cell subtypes remain stable during metastatic evolution 
856 4 0 |u https://doi.org/10.1016/j.eururo.2023.03.020  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0302283823026982  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20240916 
993 |a Article 
994 |a 2024 
998 |g 128501014  |a Erben, Philipp  |m 128501014:Erben, Philipp  |d 60000  |d 63100  |e 60000PE128501014  |e 63100PE128501014  |k 0/60000/  |k 1/60000/63100/  |p 8 
999 |a KXP-PPN1902568621  |e 4580215877 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"April 2024"}],"language":["eng"],"relHost":[{"recId":"300191596","pubHistory":["Nachgewiesen 2.1976 -"],"disp":"Molecular urothelial tumor cell subtypes remain stable during metastatic evolutionEuropean urology","note":["Ungezählte Beil. bis 40.2001: Supplement"],"id":{"eki":["300191596"],"zdb":["1482253-2"],"issn":["1873-7560","1421-993X"]},"title":[{"subtitle":"official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology","title":"European urology","title_sort":"European urology"}],"origin":[{"publisher":"Elsevier Science ; Karger","dateIssuedKey":"1976","publisherPlace":"Amsterdam [u.a.] ; Basel","dateIssuedDisp":"1976-"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"pages":"328-332","extent":"5","year":"2024","volume":"85","issue":"4","text":"85(2024), 4 vom: Apr., Seite 328-332"}}],"physDesc":[{"noteIll":"Illustrationen","extent":"5 S."}],"person":[{"family":"Cox","roleDisplay":"VerfasserIn","role":"aut","display":"Cox, Alexander","given":"Alexander"},{"roleDisplay":"VerfasserIn","family":"Klümper","given":"Niklas","role":"aut","display":"Klümper, Niklas"},{"role":"aut","display":"Stein, Johannes","given":"Johannes","roleDisplay":"VerfasserIn","family":"Stein"},{"given":"Danijel","display":"Sikic, Danijel","role":"aut","roleDisplay":"VerfasserIn","family":"Sikic"},{"roleDisplay":"VerfasserIn","family":"Breyer","given":"Johannes","role":"aut","display":"Breyer, Johannes"},{"roleDisplay":"VerfasserIn","family":"Bolenz","role":"aut","display":"Bolenz, Christian","given":"Christian"},{"family":"Roghmann","roleDisplay":"VerfasserIn","given":"Florian Bernhard Gerhard","display":"Roghmann, Florian Bernhard Gerhard","role":"aut"},{"roleDisplay":"VerfasserIn","family":"Erben","given":"Philipp","display":"Erben, Philipp","role":"aut"},{"family":"Wirtz","roleDisplay":"VerfasserIn","given":"Ralph M.","display":"Wirtz, Ralph M.","role":"aut"},{"family":"Wullich","roleDisplay":"VerfasserIn","given":"Bernd","role":"aut","display":"Wullich, Bernd"},{"display":"Ritter, Manuel","role":"aut","given":"Manuel","family":"Ritter","roleDisplay":"VerfasserIn"},{"given":"Michael","display":"Hölzel, Michael","role":"aut","family":"Hölzel","roleDisplay":"VerfasserIn"},{"family":"Schwamborn","roleDisplay":"VerfasserIn","display":"Schwamborn, Kristina","role":"aut","given":"Kristina"},{"family":"Horn","roleDisplay":"VerfasserIn","role":"aut","display":"Horn, Thomas","given":"Thomas"},{"display":"Gschwend, Jürgen E.","role":"aut","given":"Jürgen E.","family":"Gschwend","roleDisplay":"VerfasserIn"},{"display":"Hartmann, Arndt","role":"aut","given":"Arndt","roleDisplay":"VerfasserIn","family":"Hartmann"},{"roleDisplay":"VerfasserIn","family":"Weichert","given":"Wilko","display":"Weichert, Wilko","role":"aut"},{"roleDisplay":"VerfasserIn","family":"Erlmeier","role":"aut","display":"Erlmeier, Franziska","given":"Franziska"},{"roleDisplay":"VerfasserIn","family":"Eckstein","role":"aut","display":"Eckstein, Markus","given":"Markus"}],"name":{"displayForm":["Alexander Cox, Niklas Klümper, Johannes Stein, Danijel Sikic, Johannes Breyer, Christian Bolenz, Florian Roghmann, Philipp Erben, Ralph M. Wirtz, Bernd Wullich, Manuel Ritter, Michael Hölzel, Kristina Schwamborn, Thomas Horn, Jürgen Gschwend, Arndt Hartmann, Wilko Weichert, Franziska Erlmeier, Markus Eckstein"]},"note":["Online verfügbar: 6. April 2023, Artikelversion: 12. März 2024","Gesehen am 16.09.2024"],"recId":"1902568621","id":{"doi":["10.1016/j.eururo.2023.03.020"],"eki":["1902568621"]},"title":[{"title":"Molecular urothelial tumor cell subtypes remain stable during metastatic evolution","title_sort":"Molecular urothelial tumor cell subtypes remain stable during metastatic evolution"}]} 
SRT |a COXALEXANDMOLECULARU2024